Rachel A. Altura
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer-related Molecular Pathways, Cell death mechanisms and regulation, Peptidase Inhibition and Analysis, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Survivin splice variants regulate the balance between proliferation and cell death(2005)202 cited
- → Aberrant Regulation of Survivin by the RB/E2F Family of Proteins(2004)160 cited
- → Survivin 2α: a novel Survivin splice variant expressed in human malignancies(2005)156 cited
- → Aging brain microenvironment decreases hippocampal neurogenesis through Wnt‐mediated survivin signaling(2012)151 cited
- The CRM1 nuclear export protein in normal development and disease.(2012)
- → Novel mechanisms of PIEZO1 dysfunction in hereditary xerocytosis(2017)130 cited
- → Essential Role for Survivin in Early Brain Development(2005)125 cited
- → Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation(2017)111 cited
- → XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer(2014)101 cited
- → Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity(2010)96 cited